Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

166749

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much has been allocated to improving access to (a) intensity-modulated radiation therapy, (b) image-guided radiation therapy and (c) stereotactic radiotherapy in (i) 2014-15 and (ii) 2015-16.
tabling member constituency	Copeland
tabling member printed	Mr Jamie Reed
uin	216389
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>NHS England is committed to increasing access to treatments and techniques of proven clinical benefit. There are no specific financial figures for each element as the expenditure is in the Area Team budgets.</p><p> </p><p><strong> </strong></p><p> </p><p>The Prime Minister set an ambitious challenge to the National Health Service to ensure that a minimum of 24% of patients who required radical radiotherapy were able to access inverse planned Intensity Modulated Radiotherapy (IMRT) from April 2013. This ambition was achieved in May 2014. The success of this planned expansion of access is demonstrated in the increase in the number IMRT episodes, which have risen from just over 8,500 per year in 2012-13 to a projected figure of over 25,000 for 2014-15.</p><p> </p><p> </p><p> </p><p>NHS England launched a 12 week consultation on proposed changes to the shape of Stereotactic Radiosurgery and Stereotactic Radiotherapy services across the country on 3 November 2014, which will run until 26 January 2015. Following this consultation, and once a decision has been made by NHS England about the future configuration of services; NHS England will launch a procurement exercise to ensure the right level of service is accessible to patients, regardless of where they live.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/12/2014 17:28:18 answering member 3918 label Biography information for Jane Ellison
tabling member	1503 label Biography information for Mr Jamie Reed

166750

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Thalidomide
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has had with his counterpart in the German government about (a) that government's role in the criminal process relating to thalidomide and (b) compensation for all those affected by that drug; and if he will make a statement.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	216387
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>I wrote to Manuela Schwesig, Federal Minister of Family Affairs, Senior Citizens, Women and Youth, on 14 October 2014, asking if she would meet with representatives of the Thalidomide Trust. The specific issues of the German Government’s role in the criminal process and compensation for those affected by the drug were not addressed but we understand that these are the matters that the Thalidomide Trust wishes to discuss with the German Government.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 03/12/2014 16:34:50 answering member 1439 label Biography information for Norman Lamb
tabling member	432 label Biography information for Helen Jones

166755

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes: Learning Disability
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many residential care home places for people with learning difficulties there have been in each local authority area in each of the last 10 years.
tabling member constituency	Burton
tabling member printed	Andrew Griffiths
uin	216415
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>We do not hold information centrally on people with learning disabilities in residential care disaggregated by gender and type of disability.</p><p> </p><p> </p><p> </p><p>Information on people with learning disabilities disaggregated by age group and local authority that were in residential care in each of the last 10 years is attached.</p><p> </p><p> </p><p> </p><p>We do not hold information centrally on how many residential care home places for people with learning difficulties there have been in each local authority area in each of the last 10 years.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 216413 question first answered 03/12/2014 17:37:39 answering member 1439 label Biography information for Norman Lamb attachment 1 file name Learning disabilities and residential care 2004-14.xlsx title Learning disabilities and residential care 2004-14
tabling member	3936 label Biography information for Andrew Griffiths

166757

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes: Learning Disability
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in England with learning disabilities of each (a) gender, (b) age group, (c) local authority and (d) type of disability were in residential care in each of the last 10 years.
tabling member constituency	Burton
tabling member printed	Andrew Griffiths
uin	216413
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>We do not hold information centrally on people with learning disabilities in residential care disaggregated by gender and type of disability.</p><p> </p><p> </p><p> </p><p>Information on people with learning disabilities disaggregated by age group and local authority that were in residential care in each of the last 10 years is attached.</p><p> </p><p> </p><p> </p><p>We do not hold information centrally on how many residential care home places for people with learning difficulties there have been in each local authority area in each of the last 10 years.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 216415 question first answered 03/12/2014 17:37:36 answering member 1439 label Biography information for Norman Lamb attachment 1 file name Learning disabilities and residential care 2004-14.xlsx title Learning disabilities and residential care 2004-14
tabling member	3936 label Biography information for Andrew Griffiths

166765

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hazardous Substances: Waste Disposal
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to ensure that sufficient assessment of modern hazardous waste sites has been undertaken by the Health Protection Agency to enable understanding of the potential public health risks associated with such sites.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216467
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The former Health Protection Agency (HPA) became part of Public Health England (PHE) in April 2013.</p><p> </p><p> </p><p> </p><p>In 2011, the HPA published a review of the ‘Impact on Health of Emissions from Landfill Sites’. This review included landfills for hazardous waste. The review considered research from the Environment Agency, peer reviewed epidemiological studies and statements from the independent expert committee, the Committee on Toxicity of Chemicals in Food, Consumer products and the Environment.</p><p> </p><p> </p><p> </p><p>The review concluded that there has been no new evidence to change the previous advice that living close to a well-managed modern landfill site does not pose a significant risk to human health. As noted in the review, detailed site-specific risk assessment should remain an important part of the permitting and management process. PHE is consulted by the Environment Agency when they receive permit applications and variations for landfill sites, to ensure that public health is protected.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/12/2014 17:05:23 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

166766

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to ensure that all treatments for advanced pancreatic cancer shown to be effective are made available to patients on the NHS.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216468
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>The Government is committed to ensuring that patients have access to effective treatments, including those for pancreatic cancer, on terms that represent value to the National Health Service and the taxpayer.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies.</p><p> </p><p> </p><p> </p><p>NICE has recommended gemcitabine as a treatment option for pancreatic cancer in technology appraisal guidance published in May 2001, subject to certain clinical criteria, and has been asked to appraise a number of other pancreatic cancer drugs. NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance.</p><p> </p><p> </p><p> </p><p>Surgery, radiotherapy and chemotherapy treatments that may be used for pancreatic cancer are commissioned by NHS England. NHS England’s pancreatic cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective pancreatic cancer services.</p><p> </p><p> </p><p> </p><p>NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK - one of which will be on pancreatic cancer - into the use of Stereotactic Ablative Radiotherapy (SABR), an innovative radiotherapy treatment. This will allow patients to receive SABR treatment where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of this treatment so that, if it proves to be effective, it will be available for patients on the NHS where appropriate.</p><p> </p><p><strong> </strong></p><p> </p><p>We are commissioning an external review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for NHS patients to cost-effective new diagnostics, medicines and devices.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 03/12/2014 17:17:38 answering member 4020 label Biography information for George Freeman
tabling member	1538 label Biography information for Rosie Cooper

166767

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pressure Sores
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of the proportion of pressure ulcers that are caused by poor continence care.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216469
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Information concerning the cost of treating pressure ulcers is not separately identifiable within the reference costs that National Health Service trusts and NHS foundation trusts submit annually to the Department.</p><p> </p><p> </p><p> </p><p>NHS England has advised that no assessment has been made of the proportion of pressure ulcers that are caused by poor continence care. However, maintaining skin integrity and maintaining continence are both aspects of fundamental care.</p><p> </p><p> </p><p> </p><p>The NHS Safety Thermometer is the measurement tool for a programme of work to support patient safety improvement. It is used to record patient harms at the frontline, and to provide immediate information and analyses for frontline teams to monitor their performance in delivering harm free care.</p><p> </p><p>The NHS Safety Thermometer records the presence or absence of four harms:</p><p> </p><p>- pressure ulcers;</p><p> </p><p>- falls;</p><p> </p><p>- urinary tract infections in patients with a catheter; and</p><p> </p><p>- new venous thromboembolisms.</p><p> </p><p>These four harms were selected as the focus by the Department’s QIPP Safe Care programme because they are common, and because there is a clinical consensus that they are largely preventable through appropriate patient care. The concept of Harm Free Care was designed to bring focus to the patient’s overall experience. Patients are assessed in their care settings. Measurement at the frontline is intended to focus attention on patient harms and their elimination.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 216470 question first answered 03/12/2014 17:43:06 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

166768

registered interest
date	28/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pressure Sores
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the NHS has spent on treating pressure ulcers in each of the last five years.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	216470
answer	answer is ministerial correction date of answer 03/12/2014 answer text <p>Information concerning the cost of treating pressure ulcers is not separately identifiable within the reference costs that National Health Service trusts and NHS foundation trusts submit annually to the Department.</p><p> </p><p> </p><p> </p><p>NHS England has advised that no assessment has been made of the proportion of pressure ulcers that are caused by poor continence care. However, maintaining skin integrity and maintaining continence are both aspects of fundamental care.</p><p> </p><p> </p><p> </p><p>The NHS Safety Thermometer is the measurement tool for a programme of work to support patient safety improvement. It is used to record patient harms at the frontline, and to provide immediate information and analyses for frontline teams to monitor their performance in delivering harm free care.</p><p> </p><p>The NHS Safety Thermometer records the presence or absence of four harms:</p><p> </p><p>- pressure ulcers;</p><p> </p><p>- falls;</p><p> </p><p>- urinary tract infections in patients with a catheter; and</p><p> </p><p>- new venous thromboembolisms.</p><p> </p><p>These four harms were selected as the focus by the Department’s QIPP Safe Care programme because they are common, and because there is a clinical consensus that they are largely preventable through appropriate patient care. The concept of Harm Free Care was designed to bring focus to the patient’s overall experience. Patients are assessed in their care settings. Measurement at the frontline is intended to focus attention on patient harms and their elimination.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 216469 question first answered 03/12/2014 17:43:06 answering member 1439 label Biography information for Norman Lamb
tabling member	1538 label Biography information for Rosie Cooper

166559

registered interest
date	27/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Strategy Ministerial Advisory Group
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many times the Ministerial Advisory Group on Mental Health has met to date.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	216332
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>The Ministerial Advisory Group on Mental Health has met seven times, to date, with the next meeting due to take place on 17 December 2014.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 02/12/2014 14:57:16 answering member 1439 label Biography information for Norman Lamb
tabling member	4036 label Biography information for Luciana Berger

166560

registered interest
date	27/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lung Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to improve care for lung cancer patients diagnosed through emergency routes.
tabling member constituency	Brecon and Radnorshire
tabling member printed	Roger Williams
uin	216325
answer	answer is ministerial correction date of answer 02/12/2014 answer text <p>The Government is investing £450 million in raising awareness and achieving earlier diagnosis to ensure people are diagnosed with cancer before they present through an emergency route. NHS England are currently working on developing the new care models set out in the Five Year Forward View, which will help ensure that there are sufficient numbers of general practitioners (GPs) working in larger practices with greater access to diagnostic and specialist advice.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is in the process of updating the Referral Guidelines for Suspected Cancer (2005) to ensure that it reflects latest evidence and can continue to support GPs to identify patients with the symptoms of suspected cancer and urgently refer them as appropriate. NICE’s draft is currently out for consultation until 9 January 2015. The anticipated publication date for the revised guidelines is May 2015.</p><p> </p><p> </p><p> </p><p>The Department ran a national Be Clear on Cancer lung cancer campaign from May to July 2012 to raise awareness of persistent cough as a symptom of lung cancer and to encourage people with this symptom to visit their GP. Public Health England took over running of Be Clear on Cancer campaigns in April 2013 and have since run two repeat national lung cancer campaigns in July-August 2013 and March-April 2014.</p><p> </p><p> </p><p> </p><p>In 2012, to increase the awareness of cancer amongst GPs and support GPs to assess all patients more effectively, the Department funded the British Medical Journal (BMJ) Learning to provide an e-learning tool for GPs. The modules include tackling late diagnosis; risk assessment tools; and cancer pathway and the role of primary care.</p><p> </p><p> </p><p> </p><p>In 2013, Macmillan Cancer Support, partly funded by the Department, piloted an electronic cancer decision support (CDS) tool for GPs to use in their routine practice. It is designed to help GPs recognise the symptoms of cancer and identify patients that they might not otherwise refer urgently for suspected cancer. The CDS covers lung cancer and a number of other cancers. Following the pilot, Macmillan is now offering the tool free of charge to all GPs in the United Kingdom.</p><p> </p><p> </p><p> </p><p>In March 2012 NICE published the Lung cancer Quality Standard. This quality standard describes markers of high-quality, cost-effective care that, when delivered collectively, should contribute to improving the effectiveness, safety and experience of care for people with lung cancer.</p><p> </p><p> </p><p> </p><p>We know from the 2013 National Lung Cancer Audit that there have been continued increases in curative surgery for lung cancer patients. The audit report supports providers and commissioners and NHS England to reduce variation in services and drive improvement locally. We are also providing improved access to treatment through other means, such as the Cancer Drugs Fund. With the development of the chemotherapy dataset, we now have detailed information about chemotherapy drug treatment for lung cancer patients.</p><p> </p><p><strong> </strong></p><p> </p><p>Work is also underway to support early diagnosis through delivery of transparent data about performance in outcomes. For example, indicators on stage of diagnosis of cancer and diagnosis through emergency routes are part of the clinical commissioning group outcomes indicator set, which support clinical commissioning groups to understand how their local communities are performing in relation to cancer outcomes.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/12/2014 17:25:33 answering member 3918 label Biography information for Jane Ellison
tabling member	1394 label Biography information for Roger Williams